Transcatheter Versus Surgical Closure of Perimembranous Ventricular Septal Defects in Children

Abstract

Transcatheter device closure and surgical repair are effective interventions with excellent midterm results for treating pmVSD in children. Transcatheter device closure has a lower incidence of myocardial injury, less blood transfused, faster recovery, shorter hospital stay, and lower medical expenses. (Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects; NCT00890799).

Pattern of Congenital Heart Diseases and Treatment Options in a Bangladeshi Centre: Analysis of 6914 cases from Non-invasive Cardiac Laboratory

“…A comparative study of surgical versus device closure of perimembranous VSD showed excellent midterm outcome. 20 Device closure cases had less myocardial injury, fast recovery, short hospital stay and lower medical expense. In our series no complications noticed in device closure group.…”

Iatrogenic ventricular septal defect: A rare complication of surgical reconstruction of mitral paravalvular dehiscence

“…Although iatrogenic ventricular septal defects (VSDs) have been reported after aortic and mitral valve replacement [1], to our knowledge this complication has never been yet described in the English literature. Most of the reported cases dealt with successful surgical or percutaneous closure based on the enormous experience gained in treating congenital VSD [2]. Despite the unfortunate end, in reporting this case we try to direct the light to the possible mechanisms that led to the development of this injury focusing on the embryological and anatomical background.…”

Almanac 2014: congenital heart disease

“…In this study, interventional closure was associated with less myocardial injury (lower Creatine Kinase -MB (CK-MB) and cTnI levels), shorter hospital stays, reduced medical costs and faster recovery times. 28 The authors state that interventional closure appears to be the method of choice. However, at 2 years of follow-up there was no difference in closure rate, adverse events, and complications between groups and the issue of late atrioventricular block remains to be addressed.…”